Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine for stable tubal ectopic pregnancy
ACTRN12617001118392Phase 2Recruiting
- Sponsor
- North Shore University Hospital
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine in Ectopic pregnancy (EP), sponsored by North Shore University Hospital. Primary endpoint: Safety, toxicity and tolerability of vinorelbine. Started Aug 2018; status: recruiting.
02
Drugs
vinorelbine
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on ACTRN12617001118392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001118392.